Sandeep Bhapkar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin
  Critical Care Research and Practice 2022 DOI: 10.1155/2022/2668199
  +Save
• Real-World Evidence of Efficacy and Safety of Levonadifloxacin (Oral and IV) in the Management of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Findings of a Retrospective, Multi-Center Study
  Cureus 2022 DOI: 10.7759/cureus.24299
  +Save
• Efficacy and Safety of Levonadifloxacin in the Management of Community-Acquired Bacterial Pneumonia (CABP): Findings of a Retrospective, Real-World, Multi-centre Study
  International Journal of Innovative Research in Medical Science 2021 DOI: 10.23958/ijirms/vol06-i12/1295
  +Save
• Case Report of Endovascular Thrombectomy in Severe Acute Ischemic Stroke After Dabigatran Reversal with Idarucizumab
  Journal of Stroke Medicine 2019 DOI: 10.1177/2516608519864761
  +Save
• Successful use of idarucizumab for the management of intracranial hemorrhage in an elderly woman receiving dabigatran for stroke prevention in atrial fibrillation: A case report
  IHJ Cardiovascular Case Reports (CVCR) 2018 DOI: 10.1016/j.ihjccr.2018.08.013
  +Save